Detalles de la búsqueda
1.
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21260744
2.
SARS-CoV-2 breakthrough infection during the Delta-dominant epidemic and neutralizing antibodies against Omicron in comparison with the third dose of BNT162b2: a matched analysis
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22276682
3.
Association study of HLA with the kinetics of SARS-CoV-2 spike specific IgG antibody responses to BNT162b2 mRNA vaccine
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270285
4.
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265632
5.
COVID-19 breakthrough infections and pre-infection neutralizing antibody
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265301
6.
Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22280009
Resultados
1 -
6
de 6
1
Próxima >
>>